June 18, 2020 / 3:40 AM / a month ago

BRIEF-Rexahn Says Co And Ocuphire Enter Into Definitive Merger Agreement

June 17 (Reuters) - Rexahn Pharmaceuticals Inc:

* REXAHN AND OCUPHIRE ENTER INTO DEFINITIVE MERGER AGREEMENT

* $21.15 MILLION INVESTMENT COMMITTED BY INSTITUTIONAL HEALTHCARE AND ACCREDITED INVESTORS

* COMBINED CO TO CHANGE NAME TO OCUPHIRE PHARMA AND IS EXPECTED TO TRADE ON NASDAQ CAPITAL MARKET UNDER TICKER SYMBOL “OCUP.”

* FOLLOWING CLOSING, REXAHN WILL ISSUE WARRANTS TO PURCHASE SHARES OF CO’S COMMON STOCK, ADDITIONAL SHARES OF REXAHN COMMON STOCK

* FOLLOWING MERGER, MINA SOOCH WILL BE APPOINTED COMBINED CO’S PRESIDENT AND CHIEF EXECUTIVE OFFICER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below